CoChat

Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future

Mikaelian, Igor, Cameron, Mark, Dalmas, Deidre A., Enerson, Bradley E., Gonzalez, Raymond J., Guionaud, Silvia, Hoffmann, Peter K., King, Nicholas M. P., Lawton, Michael P., Scicchitano, Marshall S., Smith, Holly W., Thomas, Roberta A., Weaver, James L., Zabka, Tanja S., The Vascular Injury Working Group of the Predictive Safety Consortium · 2014 · Toxicologic Pathology
Cited by 46

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Better biomarkers are needed to identify, characterize, and/or monitor drug-induced vascular injury (DIVI) in nonclinical species and patients. The Predictive Safety Testing Consortium (PSTC), a precompetitive collaboration of pharmaceutical companies and the U.S. Food and Drug Administration (FDA), formed the Vascular Injury Working Group (VIWG) to develop and qualify translatable biomarkers of DIVI. The VIWG focused its research on acute DIVI because early detection for clinical and nonclinical safety monitoring is desirable. The VIWG developed a strategy based on the premise that biomarkers of DIVI in rat would be translatable to humans due to the morphologic similarity of vascular injury between species regardless of mechanism. The histomorphologic lexicon for DIVI in rat defines degenerative and adaptive findings of the vascular endothelium and smooth muscles, and characterizes inflammatory components. We describe the mechanisms of these changes and their associations with candidate biomarkers for which advanced analytical method validation was completed. Further development is recommended for circulating microRNAs, endothelial microparticles, and imaging techniques. Recommendations for sample collection and processing, analytical methods, and confirmation of target localization using immunohistochemistry and in situ hybridization are described. The methods described are anticipated to aid in the identification and qualification of translational biomarkers for DIVI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0192623314525686

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 46

Metadata

Authors
Mikaelian, I., Cameron, M., Dalmas, D. A., Enerson, B. E., Gonzalez, R. J., Guionaud, S., Hoffmann, P. K., King, N. M. P., Lawton, M. P., Scicchitano, M. S., Smith, H. W., Thomas, R. A., Weaver, J. L., Zabka, T. S., & The Vascular Injury Working Group of the Predictive Safety Consortium
Venue
Toxicologic Pathology
Published
2014-04-28
Volume
42
Issue
4
Pages
635-657
ISSN
  • 0192-6233 (ISSN-L)
  • 1533-1601
OpenAlex
W2170549192
Cited by
46
References
12
FWCI
3.11
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future. https://app.cochat.ai/papers/10.1177/0192623314525686
The paper
Mikaelian, I., Cameron, M., Dalmas, D. A., Enerson, B. E., Gonzalez, R. J., Guionaud, S., Hoffmann, P. K., King, N. M. P., Lawton, M. P., Scicchitano, M. S., Smith, H. W., Thomas, R. A., Weaver, J. L., Zabka, T. S., & The Vascular Injury Working Group of the Predictive Safety Consortium. (2014). Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future. Toxicologic Pathology. https://doi.org/10.1177/0192623314525686

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.